Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trichuris suis ova (TSO) in relapsing-remitting multiple sclerosis and clinically isolated syndrome
2009-015319-41Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2011
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) and clinically isolated syndrome (CIS) comparing TSO with Placebo (2 arms). Primary endpoint: Number of new T2 lesions on cranial MRI. Started Feb 2011; status: terminated.
02
Drugs
trichuris suis ova
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on 2009-015319-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015319-41.